Andres Tapia del Fierro

Andres Tapia del Fierro

Auto-generated profile, based on publicly available information

Andres Tapia del Fierro

The Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 September 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
AFAndres Tapia del Fierro
Andres Tapia del Fierro
BHBianca Den Hamer
Bianca Den Hamer
NBNatalia Benetti
Natalia Benetti
NJNatasha Jansz
Natasha Jansz
KCKelan Chen
Kelan Chen
MBMarnie E. Blewitt
Marnie E. Blewitt
The interplay between 3D chromatin architecture and gene silencing is incompletely understood. Here, we report a novel point mutation in the non-canonical SMC protein SMCHD1 that enhances its silencing capacity at endogenous developmental targets. Moreover, it also results in enhanced silencing at the facioscapulohumeral muscular dystrophy associated macrosatellite-array, D4Z4, resulting in enhanced repression of DUX4 encoded by this repeat. Heightened SMCHD1 silencing perturbs developmental Hox gene activation, causing a homeotic transformation in mice. Paradoxically, the mutant SMCHD1 appears to enhance insulation against other epigenetic regulators, including PRC2 and CTCF, while depleting long range chromatin interactions akin to what is observed in the absence of SMCHD1. These data suggest that SMCHD1’s role in long range chromatin interactions is not directly linked to gene silencing or insulating the chromatin, refining the model for how the different levels of SMCHD1-mediated chromatin regulation interact to bring about gene silencing in normal development and disease.

29 March 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
AKAndrew Keniry
Andrew Keniry
NJNatasha Jansz
Natasha Jansz
LGLinden J. Gearing
Linden J. Gearing
IWIromi Wanigasuriya
Iromi Wanigasuriya
JCJoseph Chen
Joseph Chen
MBMarnie E. Blewitt
Marnie E. Blewitt
The process of epigenetic silencing, while fundamentally important, is not yet completely understood. Here we report a replenishable female mouse embryonic stem cell (mESC) system, Xmas, that allows rapid assessment of X chromosome inactivation (XCI), the epigenetic silencing mechanism of one of the two X chromosomes that enables dosage compensation in female mammals. Through a targeted genetic screen in differentiating Xmas mESCs, we reveal that the BAF complex is required to create nucleosome-depleted regions at promoters on the inactive X chromosome during the earliest stages of establishment of XCI. Without this action gene silencing fails. Xmas mESCs provide a tractable model for screen-based approaches that enable the discovery of unknown facets of the female-specific process of XCI and epigenetic silencing more broadly.

25 July 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
NBNatalia Benetti
Natalia Benetti
QGQuentin Gouil
Quentin Gouil
AFAndres Tapia del Fierro
Andres Tapia del Fierro
TBTamara Beck
Tamara Beck
KBKelsey Breslin
Kelsey Breslin
MBMarnie E. Blewitt
Marnie E. Blewitt
Parents transmit genetic and epigenetic information to their offspring. Maternal effect genes regulate the offspring epigenome to ensure normal development. Here we report that the epigenetic regulator SMCHD1 has a maternal effect onHoxgene expression and skeletal patterning. Maternal SMCHD1, present in the oocyte and preimplantation embryo, prevents precocious activation ofHoxgenes post-implantation. Without maternal SMCHD1, highly penetrant posterior homeotic transformations occur in the embryo.Hoxgenes are decorated with Polycomb marks H2AK119ub and H3K27me3 from the oocyte throughout early embryonic development; however, loss of maternal SMCHD1 does not deplete these marks. Therefore, we propose maternal SMCHD1 acts downstream of Polycomb marks to establish a chromatin state necessary for persistent epigenetic silencing and appropriateHoxgene expression later in the developing embryo. This is a striking role for maternal SMCHD1 in long-lived epigenetic effects impacting offspring phenotype.

13 May 2021 in bioRxiv
Verified
Preprint
Open access
PDF file
AFAndres Tapia del Fierro
Andres Tapia del Fierro
BHBianca Den Hamer
Bianca Den Hamer
NJNatasha Jansz
Natasha Jansz
KCKelan Chen
Kelan Chen
TBTamara Beck
Tamara Beck
MBMarnie E Blewitt
Marnie E Blewitt
The interplay between 3D chromatin architecture and gene silencing is incompletely understood. Here, we report a novel point mutation in the non-canonical SMC protein SMCHD1 that enhances its silencing capacity at endogenous developmental targets and at the facioscapulohumeral muscular dystrophy associated macro-array, D4Z4. Heightened SMCHD1 silencing perturbs developmental Hox gene activation, causing a homeotic transformation in mice. Paradoxically, the mutant SMCHD1 appears to enhance insulation against another epigenetic regulator complex, PRC2, while depleting long range chromatin interactions akin to what is observed in the absence of SMCHD1. These data suggest that SMCHD1’s role in long range chromatin interactions is not directly linked to gene silencing or insulating the chromatin, refining the model for how the different levels of SMCHD1-mediated chromatin regulation interact to bring about gene silencing in normal development and disease.